DK1042349T3 - Anvendelse af polyamid-nukleinsyre-oligomerer til frembringelse af et biologisk respons - Google Patents

Anvendelse af polyamid-nukleinsyre-oligomerer til frembringelse af et biologisk respons

Info

Publication number
DK1042349T3
DK1042349T3 DK98953610T DK98953610T DK1042349T3 DK 1042349 T3 DK1042349 T3 DK 1042349T3 DK 98953610 T DK98953610 T DK 98953610T DK 98953610 T DK98953610 T DK 98953610T DK 1042349 T3 DK1042349 T3 DK 1042349T3
Authority
DK
Denmark
Prior art keywords
pna oligomers
materials
biological response
oligomers
provides methods
Prior art date
Application number
DK98953610T
Other languages
English (en)
Inventor
Elliott Richelson
Beth Marie Tyler
Daniel J Mccormick
Bernadette Marie Cusack
Clark V Hoshall
Christopher Lee Douglas
Karen Jansen
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/953,269 external-priority patent/US6472209B1/en
Priority claimed from US09/168,791 external-priority patent/US6723560B2/en
Application filed by Mayo Foundation filed Critical Mayo Foundation
Application granted granted Critical
Publication of DK1042349T3 publication Critical patent/DK1042349T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
    • C12N2310/3181—Peptide nucleic acid, PNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
DK98953610T 1997-10-17 1998-10-16 Anvendelse af polyamid-nukleinsyre-oligomerer til frembringelse af et biologisk respons DK1042349T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/953,269 US6472209B1 (en) 1997-10-17 1997-10-17 Using polyamide nucleic acid oligomers to engender a biological response
US09/016,685 US6743627B1 (en) 1997-10-17 1998-01-30 Using polyamide nucleic acid oligomers to engender a biological response
US16851998A 1998-10-08 1998-10-08
US09/168,791 US6723560B2 (en) 1998-10-08 1998-10-08 Using polyamide nucleic acid oligomers to engender a biological response
US09/168,714 US6989270B1 (en) 1997-10-17 1998-10-08 Using polyamide nucleic acid oligomers to engender a biological response
PCT/US1998/021888 WO1999020643A1 (en) 1997-10-17 1998-10-16 Using polyamide nucleic acid oligomers to engender a biological response

Publications (1)

Publication Number Publication Date
DK1042349T3 true DK1042349T3 (da) 2008-11-10

Family

ID=27533701

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98953610T DK1042349T3 (da) 1997-10-17 1998-10-16 Anvendelse af polyamid-nukleinsyre-oligomerer til frembringelse af et biologisk respons

Country Status (12)

Country Link
US (1) US6989270B1 (da)
EP (1) EP1042349B1 (da)
JP (1) JP2003523307A (da)
AT (1) ATE405575T1 (da)
AU (1) AU741246B2 (da)
BR (1) BR9814866A (da)
CA (1) CA2306731A1 (da)
DE (1) DE69839921D1 (da)
DK (1) DK1042349T3 (da)
ES (1) ES2312192T3 (da)
IL (1) IL135705A0 (da)
WO (1) WO1999020643A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723560B2 (en) * 1998-10-08 2004-04-20 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
US6472209B1 (en) 1997-10-17 2002-10-29 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
US6989270B1 (en) 1997-10-17 2006-01-24 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
US6806363B1 (en) 1999-04-16 2004-10-19 Mayo Foundation For Medical Education & Research Cobalamin conjugates useful as antitumor agents
TWI228512B (en) 2000-10-25 2005-03-01 Mayo Foundation Transcobalamin binding conjugates useful for treating abnormal cellular proliferation

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005519A1 (en) 1985-03-15 1986-09-25 James Summerton Polynucleotide assay reagent and method
US5217866A (en) 1985-03-15 1993-06-08 Anti-Gene Development Group Polynucleotide assay reagent and method
US5470974A (en) 1985-03-15 1995-11-28 Neu-Gene Development Group Uncharged polynucleotide-binding polymers
US5783682A (en) 1990-07-27 1998-07-21 Isis Pharmaceuticals, Inc. Oligonucleotide mimics having nitrogen-containing linkages
US5719262A (en) 1993-11-22 1998-02-17 Buchardt, Deceased; Ole Peptide nucleic acids having amino acid side chains
DK51092D0 (da) 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
US5641625A (en) 1992-05-22 1997-06-24 Isis Pharmaceuticals, Inc. Cleaving double-stranded DNA with peptide nucleic acids
WO1995004749A1 (en) 1993-08-05 1995-02-16 Isis Pharmaceuticals, Inc. Oligomers for modulating metabolic function
AU7523794A (en) 1993-08-09 1995-02-28 Isis Pharmaceuticals, Inc. Oligomers for modulating viral processes
US6156501A (en) 1993-10-26 2000-12-05 Affymetrix, Inc. Arrays of modified nucleic acid probes and methods of use
GB2284209A (en) 1993-11-25 1995-05-31 Ole Buchardt Nucleic acid analogue-induced transcription of RNA from a double-stranded DNA template
US5703067A (en) * 1995-05-08 1997-12-30 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO1996035705A1 (en) 1995-05-10 1996-11-14 Isis Pharmaceuticals, Inc. Inhibition of transcription factor-mediated transcriptional activation by oligomer strand invasion
US6015710A (en) 1996-04-09 2000-01-18 The University Of Texas System Modulation of mammalian telomerase by peptide nucleic acids
GB9608803D0 (en) 1996-04-27 1996-07-03 Univ Newcastle Mitochondrial dna defects
IL133087A0 (en) 1997-05-28 2001-03-19 Nielsen Peter E Conjugated peptide nucleic acids having enhanced cellular uptake
CA2298067A1 (en) 1997-07-24 1999-02-04 Ulo Langel Conjugates of transporter peptides and nucleic acid analogs, and their use
US6300318B1 (en) 1997-09-16 2001-10-09 Peter E. Nielsen Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor
AU9570898A (en) 1997-09-18 1999-04-05 Gene Therapy Systems, Inc. Chemical modification of dna using peptide nucleic acid conjugates
US6472209B1 (en) * 1997-10-17 2002-10-29 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
US6989270B1 (en) 1997-10-17 2006-01-24 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response

Also Published As

Publication number Publication date
WO1999020643A9 (en) 1999-08-05
CA2306731A1 (en) 1999-04-29
JP2003523307A (ja) 2003-08-05
AU1094099A (en) 1999-05-10
IL135705A0 (en) 2001-05-20
EP1042349A1 (en) 2000-10-11
WO1999020643A1 (en) 1999-04-29
ATE405575T1 (de) 2008-09-15
EP1042349B1 (en) 2008-08-20
US6989270B1 (en) 2006-01-24
EP1042349A4 (en) 2004-07-28
AU741246B2 (en) 2001-11-29
ES2312192T3 (es) 2009-02-16
BR9814866A (pt) 2001-11-20
DE69839921D1 (de) 2008-10-02

Similar Documents

Publication Publication Date Title
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
ATE319855T1 (de) Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung
ATE335845T1 (de) Elektrophoretische analyse von molekülen mit immobilisierten sonden
DE69033067D1 (de) 4,7-dichlorfluoreszein-farbstoffe als molekulare sonden
DE69918130D1 (de) Verwendung von vereinigten sonden zur genetischen analyse
DK1044374T3 (da) Glucosebiosensor
SE0003286D0 (sv) Method and kit for human identification
ATE368125T1 (de) Verfahren zur erkennung von einzel-nukleotid- polymorphismen
ATE291583T1 (de) Polymorphismus von mononukleotiden und ihre verwendung in der genanalyse
PT921395E (pt) Ensaio para medicao de fragmentos de proteina em meios biologicos
BR9812783A (pt) "sistemas de detecção para o registro de interações e as relações funcionais de proteìnas"
ATE321886T1 (de) Oligonukleotide und diese enthaltende komplexe zur detektion der anwesenheit oder abwesenheit einer zielnukleinsäure in einer probe
ATE318930T1 (de) Nukleinsäuresonden zur detektion von candida- spezies
ATE404866T1 (de) System und verfahren zur in-vitro-analyse von therapeutischen wirkstoffen
ATE239274T1 (de) Proteom-analyse zum charakterisieren von auf- und abgeregelten proteinen in biologischen proben
ATE229571T1 (de) Nachweis und identifizierung von nicht-polio enteroviren
PT696642E (pt) Processo para a identificacao de pertuebacoes do sistema proteina c / proteina s
ES2154736T3 (es) Metodo de analisis.
WO2001042503A3 (en) Apparatus and methods for drug screening based on nucleic acid analysis
IL135705A0 (en) Using polyamide nuceic acid oligomers to engender a biological response
EP1083980A4 (en) MODULATION OF MOLECULAR INTERACTION POSITIONS IN RNS AND OTHER BIOMOLECULES
ATE261125T1 (de) Erkennung von tmorspezifische genprodukte
FR2799281B1 (fr) Procede et dispositif de detection d'une reaction de reconnaissance moleculaire
Frisk et al. Substrate-modified hydrogels for autonomous sensing of botulinum neurotoxin type A
MXPA02000293A (es) Isoformas de la amp ciclico fosfodiesterasa y metodos de uso.